Literature DB >> 11068951

Impact of fatigue on quality of life in oncology patients.

G A Curt1.   

Abstract

Fatigue is the most commonly reported symptom in cancer patients and has a profound effect on patient quality of life (QOL). The Fatigue-1 and Fatigue-2 surveys performed by the Fatigue Coalition have shown that fatigue occurs on a consistent basis in approximately three quarters of patients treated for cancer. Fatigue-2 study results show that fatigue is associated with significant physical, emotional, psychologic, and social consequences, with virtually every aspect of daily life being affected. Patients also report that fatigue interferes with both their own and their caregivers' careers and economic status. Fatigue-2 documented a significant communication gap between patient and physician regarding fatigue and nonspecific physician responses to patient reports. This finding suggests that patients may benefit from physician initiation of discussion of the causes and treatments of fatigue and from physician education regarding available treatment modalities. Additional research is needed to elucidate the nature of fatigue in cancer patients. Algorithms for the differential diagnosis and treatment of cancer fatigue need to be developed and implemented to assist in timely recognition and management.

Entities:  

Mesh:

Year:  2000        PMID: 11068951     DOI: 10.1016/s0037-1963(00)90063-5

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  53 in total

1.  Effectiveness of a clinical intervention to eliminate barriers to pain and fatigue management in oncology.

Authors:  Tami Borneman; Marianna Koczywas; Virginia Sun; Barbara F Piper; Cynthia Smith-Idell; Benjamin Laroya; Gwen Uman; Betty Ferrell
Journal:  J Palliat Med       Date:  2011-01-27       Impact factor: 2.947

Review 2.  Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity.

Authors:  Kathryn H Schmitz; Marian L Neuhouser; Tanya Agurs-Collins; Krista A Zanetti; Lisa Cadmus-Bertram; Lorraine T Dean; Bettina F Drake
Journal:  J Natl Cancer Inst       Date:  2013-08-29       Impact factor: 13.506

3.  Heart rate recovery and aerobic endurance capacity in cancer survivors: interdependence and exercise-induced improvements.

Authors:  Daniel Niederer; Lutz Vogt; Javier Gonzalez-Rivera; Katharina Schmidt; Winfried Banzer
Journal:  Support Care Cancer       Date:  2015-04-03       Impact factor: 3.603

4.  Trajectories of fatigue in patients with breast cancer before, during, and after radiation therapy.

Authors:  Anand Dhruva; Marylin Dodd; Steven M Paul; Bruce A Cooper; Kathryn Lee; Claudia West; Bradley E Aouizerat; Patrick S Swift; William Wara; Christine Miaskowski
Journal:  Cancer Nurs       Date:  2010 May-Jun       Impact factor: 2.592

Review 5.  [Psycho-oncology].

Authors:  M Haeck; S Franke; J Wiskemann; K Mathiak
Journal:  Nervenarzt       Date:  2012-11       Impact factor: 1.214

6.  Quality of life in terminal care--with special reference to age, gender and marital status.

Authors:  C Lundh Hagelin; Ake Seiger; C J Fürst
Journal:  Support Care Cancer       Date:  2005-09-28       Impact factor: 3.603

Review 7.  The prevalence and severity of fatigue in men with prostate cancer: a systematic review of the literature.

Authors:  Ben Langston; Jo Armes; Anneliese Levy; Elizabeth Tidey; Emma Ream
Journal:  Support Care Cancer       Date:  2013-03-03       Impact factor: 3.603

8.  Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S.

Authors:  David H Henry; Hema N Viswanathan; Eric P Elkin; Shana Traina; Shawn Wade; David Cella
Journal:  Support Care Cancer       Date:  2008-01-17       Impact factor: 3.603

Review 9.  Iron, anaemia, and inflammatory bowel diseases.

Authors:  C Gasche; M C E Lomer; I Cavill; G Weiss
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

10.  Association of C-reactive protein and interleukin-6 with new-onset fatigue in the Whitehall II prospective cohort study.

Authors:  H J Cho; M Kivimäki; J E Bower; M R Irwin
Journal:  Psychol Med       Date:  2012-11-14       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.